- Leerink upgrades Cubist Pharmaceuticals (CBST) to Outperform from Market Perform.
- Price target hiked to $76 from $57.
Leerink sees 15% upside for Cubist
Recommended For You
More Trending News
About MRK Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| MRK | - | - |
| Merck & Co., Inc. | ||